Cost Savings Opportunity BASE10 Genetics focuses on pharmacogenomic and nutrigenomic programs to reduce prescription spend and medical claims, signaling a clear opportunity to position enhanced ROI calculations for potential clients and demonstrate measurable cost reductions.

Enterprise Readiness Despite a small team, BASE10 manages end-to-end program deployment and follow-up, suggesting scalability for mid to large health benefits programs; discuss partnerships that leverage their turnkey model to minimize client workload while maximizing ROI.

Compliance & Risk Recent hires in compliance and governance indicate a strong emphasis on regulatory adherence; approach health plans and providers with assurance on data privacy, regulatory alignment, and risk management when proposing genetic testing integrations.

Care Coordination Success factors include disease management, prevention, and improved health outcomes; explore opportunities with payer networks and employer groups seeking integrated wellness programs with measurable outcomes and patient engagement.

Partnership Potential Multiple collaborations in 2020–2022 around DNA testing and workforce health programs show openness to partnerships; target health plans, benefits brokers, and care providers for joint go-to-market efforts and pilot programs.